Patients are injected intradermally at axilla or inguinal region with dendritic cells pulsed with artificial antigens or tumor lysate (approximately 1x107). At the same time, OK432 (0.5-3KE) is inject
Sponsors
Sapporo Hokuyu Hospital
Conditions
Hematological malignanciesPatients with advanced malignancies
Phase 1
Open-labeled, non-randomized, single institute study to evaluate safety and efficacy of dendritic cell vaccination using artificial antigens or tumor lysate for patients with advanced malignancies.
Active, not recruitingJPRN-UMIN000027279
Start: 2009-04-01Target: 200Updated: 2026-06-29
Open-labeled, non-randomized, single institute study of dendritic cell therapy using artificial antigen or tumor lysate for hematological malignancies
Active, not recruitingJPRN-UMIN000028456
Start: 2009-04-01Target: 25Updated: 2026-06-29